Dataset Information

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

ABSTRACT: Plasmacytoid bladder cancer is an aggressive histologic variant with a high risk of disease-specific mortality. Using whole-exome and targeted sequencing, we find that truncating somatic alterations in the CDH1 gene occur in 84% of plasmacytoid carcinomas and are specific to this histologic variant. Consistent with the aggressive clinical behavior of plasmacytoid carcinomas, which frequently recur locally, CRISPR/Cas9-mediated knockout of CDH1 in bladder cancer cells enhanced cell migration.

SUBMITTER: Al-Ahmadie HA

PROVIDER: S-EPMC4827439 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Al-Ahmadie Hikmat A HA Iyer Gopa G Lee Byron H BH Scott Sasinya N SN Mehra Rohit R Bagrodia Aditya A Jordan Emmet J EJ Gao Sizhi Paul SP Ramirez Ricardo R Cha Eugene K EK Desai Neil B NB Zabor Emily C EC Ostrovnaya Irina I Gopalan Anuradha A Chen Ying-Bei YB Fine Samson W SW Tickoo Satish K SK Gandhi Anupama A Hreiki Joseph J Viale Agnès A Arcila Maria E ME Dalbagni Guido G Rosenberg Jonathan E JE Bochner Bernard H BH Bajorin Dean F DF Berger Michael F MF Reuter Victor E VE Taylor Barry S BS Solit David B DB

Nature genetics 20160222 4

Plasmacytoid bladder cancer is an aggressive histologic variant with a high risk of disease-specific mortality. Using whole-exome and targeted sequencing, we find that truncating somatic alterations in the CDH1 gene occur in 84% of plasmacytoid carcinomas and are specific to this histologic variant. Consistent with the aggressive clinical behavior of plasmacytoid carcinomas, which frequently recur locally, CRISPR/Cas9-mediated knockout of CDH1 in bladder cancer cells enhanced cell migration. ...[more]

PMID: 26901067

Dataset Information

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Publications

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.
| S-EPMC2427143 | biostudies-literature

Frequent truncating mutations of STAG2 in bladder cancer.
| S-EPMC3875130 | biostudies-literature

Frequent truncating mutations of STAG2 in bladder cancer
2013-06-30 | GSE41581 | GEO

Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations.
| S-EPMC5330735 | biostudies-literature

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types.
| S-EPMC5527104 | biostudies-literature

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
| S-EPMC6728909 | biostudies-literature

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
| S-EPMC7650671 | biostudies-literature

Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti.
| S-EPMC4396494 | biostudies-literature

Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites.
| S-EPMC5689640 | biostudies-literature

A catalogue of somatic NRF2 gain-of-function mutations in cancer.
| S-EPMC6110754 | biostudies-other